Abstract:Background: Aspirin circulates transiently in blood, but the identity of the enzyme(s) that hydrolyzes its acetyl residue remains unknown. Results: Purification, mass spectrometry, and overexpression identified erythrocyte type I PAF acetylhydrolase as aspirin hydrolase. Conclusion: Aspirin is primarily hydrolyzed within erythrocytes by PAF acetylhydrolase. Significance: PAF acetylhydrolase and aspirin hydrolysis varies among individuals to modulate the effectiveness of aspirin.
“…Type I PAFAH is an ␣1/␣2 heterodimer composed of independent genes (PAFAH1b2 and PAFAH1b3) that are independently regulated and have independent roles (46 -48). We previously identified the ␣1/␣2 heterodimer as the aspirin hydrolytic enzyme of erythrocytes (20), so the novel plasma ␣2 enzyme shows that this extracellular enzyme is not derived from lysed erythrocytes.…”
Section: Discussionmentioning
confidence: 99%
“…Purification of soluble fraction 1 and mass spectrometry of candidate proteins as described (20) revealed the presence of PAFAH1b2 in plasma (data not shown.) Type I PAFAH hydrolyzes acetylated phospholipids but additionally accepts aspirin as a substrate (20).…”
Section: Aspirin Is Hydrolyzed In Plasma Hydrolysis Is Highly Variabmentioning
confidence: 92%
“…Type I PAFAH hydrolyzes acetylated phospholipids but additionally accepts aspirin as a substrate (20). This intracellular enzyme is a trimer con-FIGURE 1.…”
Section: Aspirin Is Hydrolyzed In Plasma Hydrolysis Is Highly Variabmentioning
confidence: 99%
“…Aspirin is hydrolyzed in blood within erythrocytes (19) by a heterodimer of PAFAH1b2 and PAFHA1b3 (20) and also in plasma. The rate of aspirin hydrolysis by erythrocytes varies severalfold (20), with a larger variation in the rate of plasma hydrolysis (see below), so the relative contribution of the two compartments varies but is approximately similar.…”
mentioning
confidence: 99%
“…The rate of aspirin hydrolysis by erythrocytes varies severalfold (20), with a larger variation in the rate of plasma hydrolysis (see below), so the relative contribution of the two compartments varies but is approximately similar. The identity of the enzyme in plasma that hydrolyzes aspirin remains unknown.…”
Background: Aspirin use is extensive, but its short half-life limits bioavailability. Results: Butyrylcholinesterase (BChE) and PAFAH1b2 hydrolyze aspirin in plasma. Aspirin hydrolysis in plasma varies by up to 12-fold from non-genetic modulation of BChE activity. Conclusion: Two enzymes hydrolyze aspirin in plasma, and their contribution varies among individuals. Significance: Aspirin hydrolysis in plasma is variable, affecting platelet inhibition by aspirin.
“…Type I PAFAH is an ␣1/␣2 heterodimer composed of independent genes (PAFAH1b2 and PAFAH1b3) that are independently regulated and have independent roles (46 -48). We previously identified the ␣1/␣2 heterodimer as the aspirin hydrolytic enzyme of erythrocytes (20), so the novel plasma ␣2 enzyme shows that this extracellular enzyme is not derived from lysed erythrocytes.…”
Section: Discussionmentioning
confidence: 99%
“…Purification of soluble fraction 1 and mass spectrometry of candidate proteins as described (20) revealed the presence of PAFAH1b2 in plasma (data not shown.) Type I PAFAH hydrolyzes acetylated phospholipids but additionally accepts aspirin as a substrate (20).…”
Section: Aspirin Is Hydrolyzed In Plasma Hydrolysis Is Highly Variabmentioning
confidence: 92%
“…Type I PAFAH hydrolyzes acetylated phospholipids but additionally accepts aspirin as a substrate (20). This intracellular enzyme is a trimer con-FIGURE 1.…”
Section: Aspirin Is Hydrolyzed In Plasma Hydrolysis Is Highly Variabmentioning
confidence: 99%
“…Aspirin is hydrolyzed in blood within erythrocytes (19) by a heterodimer of PAFAH1b2 and PAFHA1b3 (20) and also in plasma. The rate of aspirin hydrolysis by erythrocytes varies severalfold (20), with a larger variation in the rate of plasma hydrolysis (see below), so the relative contribution of the two compartments varies but is approximately similar.…”
mentioning
confidence: 99%
“…The rate of aspirin hydrolysis by erythrocytes varies severalfold (20), with a larger variation in the rate of plasma hydrolysis (see below), so the relative contribution of the two compartments varies but is approximately similar. The identity of the enzyme in plasma that hydrolyzes aspirin remains unknown.…”
Background: Aspirin use is extensive, but its short half-life limits bioavailability. Results: Butyrylcholinesterase (BChE) and PAFAH1b2 hydrolyze aspirin in plasma. Aspirin hydrolysis in plasma varies by up to 12-fold from non-genetic modulation of BChE activity. Conclusion: Two enzymes hydrolyze aspirin in plasma, and their contribution varies among individuals. Significance: Aspirin hydrolysis in plasma is variable, affecting platelet inhibition by aspirin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.